117 related articles for article (PubMed ID: 30108326)
1. Anti-thymocyte globulin's activity against acute myeloid leukemia stem cells.
Dabas R; Dharmani-Khan P; Modi M; Van Slyke T; Luider J; Morris D; Brandwein J; Daly A; Khan FM; Storek J
Bone Marrow Transplant; 2019 Apr; 54(4):549-559. PubMed ID: 30108326
[TBL] [Abstract][Full Text] [Related]
2. More acute lymphoid leukemia than acute myeloid leukemia blasts are killed by rabbit antithymocyte globulin.
Dabas R; Khan PD; Modi M; Khan FM; Storek J
Cytotherapy; 2019 Nov; 21(11):1161-1165. PubMed ID: 31543396
[TBL] [Abstract][Full Text] [Related]
3. Antithymocyte Globulin at Clinically Relevant Concentrations Kills Leukemic Blasts.
Dabas R; Lee R; Servito MT; Dharmani-Khan P; Modi M; van Slyke T; Luider J; Durand C; Larratt L; Brandwein J; Morris D; Daly A; Khan FM; Storek J
Biol Blood Marrow Transplant; 2016 May; 22(5):815-24. PubMed ID: 26779931
[TBL] [Abstract][Full Text] [Related]
4. In vivo T cell depletion with pretransplant anti-thymocyte globulin reduces graft-versus-host disease without increasing relapse in good risk myeloid leukemia patients after stem cell transplantation from matched related donors.
Kröger N; Zabelina T; Krüger W; Renges H; Stute N; Rischewski J; Sonnenberg S; Ayuk F; Tögel F; Schade U; Fiegel H; Erttmann R; Löliger C; Zander AR
Bone Marrow Transplant; 2002 Apr; 29(8):683-9. PubMed ID: 12180114
[TBL] [Abstract][Full Text] [Related]
5. Impact of in vivo T cell depletion in HLA-identical allogeneic stem cell transplantation for acute myeloid leukemia in first complete remission conditioned with a fludarabine iv-busulfan myeloablative regimen: a report from the EBMT Acute Leukemia Working Party.
Rubio MT; D'Aveni-Piney M; Labopin M; Hamladji RM; Sanz MA; Blaise D; Ozdogu H; Daguindeau E; Richard C; Santarone S; Irrera G; Yakoub-Agha I; Yeshurun M; Diez-Martin JL; Mohty M; Savani BN; Nagler A
J Hematol Oncol; 2017 Jan; 10(1):31. PubMed ID: 28118857
[TBL] [Abstract][Full Text] [Related]
6. The putative anti-leukemic effects of anti-thymocyte globulins in patients with CD7-positive acute myeloid leukemia.
Ochi K; Fuji S; Takano K; Tajima K; Ito A; Tanaka T; Inamoto Y; Kurosawa S; Kim SW; Tojo A; Fukuda T
Bone Marrow Transplant; 2018 Aug; 53(8):1019-1029. PubMed ID: 29459664
[TBL] [Abstract][Full Text] [Related]
7. Rabbit anti T-lymphocyte globulin induces apoptosis in peripheral blood mononuclear cell compartments and leukemia cells, while hematopoetic stem cells are apoptosis resistant.
Grüllich C; Ziegler C; Finke J
Biol Blood Marrow Transplant; 2009 Feb; 15(2):173-82. PubMed ID: 19167677
[TBL] [Abstract][Full Text] [Related]
8. Association between anti-thymocyte globulin exposure and survival outcomes in adult unrelated haemopoietic cell transplantation: a multicentre, retrospective, pharmacodynamic cohort analysis.
Admiraal R; Nierkens S; de Witte MA; Petersen EJ; Fleurke GJ; Verrest L; Belitser SV; Bredius RGM; Raymakers RAP; Knibbe CAJ; Minnema MC; van Kesteren C; Kuball J; Boelens JJ
Lancet Haematol; 2017 Apr; 4(4):e183-e191. PubMed ID: 28330607
[TBL] [Abstract][Full Text] [Related]
9. Impact of low-dose rabbit anti-thymocyte globulin in unrelated hematopoietic stem cell transplantation.
Kuriyama K; Fuji S; Inamoto Y; Tajima K; Tanaka T; Inoue Y; Ito R; Hayashi Y; Ito A; Kurosawa S; Kim SW; Yamashita T; Fukuda T
Int J Hematol; 2016 Apr; 103(4):453-60. PubMed ID: 26857285
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics and pharmacodynamics of anti-thymocyte globulin in recipients of partially HLA-matched blood hematopoietic progenitor cell transplantation.
Waller EK; Langston AA; Lonial S; Cherry J; Somani J; Allen AJ; Rosenthal H; Redei I
Biol Blood Marrow Transplant; 2003 Jul; 9(7):460-71. PubMed ID: 12869960
[TBL] [Abstract][Full Text] [Related]
11. Antithymocyte globulin for the prevention of graft-versus-host disease after unrelated hematopoietic stem cell transplantation for acute myeloid leukemia: results from the multicenter German cooperative study group.
Basara N; Baurmann H; Kolbe K; Yaman A; Labopin M; Burchardt A; Huber C; Fauser AA; Schwerdtfeger R
Bone Marrow Transplant; 2005 May; 35(10):1011-8. PubMed ID: 15821768
[TBL] [Abstract][Full Text] [Related]
12. Role of thymoglobulin in matched sibling allogeneic hematopoietic stem cell transplantation with busulfan and fludarabine conditioning in myeloid malignanicies.
Shin DY; Lee JH; Park S; Lee JO; Moon JH; Ahn JS; Choi Y; Song IC; Shin HJ; Lee WS; Lee HS; Yoon SS
Bone Marrow Transplant; 2018 Feb; 53(2):207-212. PubMed ID: 29084202
[TBL] [Abstract][Full Text] [Related]
13. The increase from 2.5 to 5 mg/kg of rabbit anti-thymocyte-globulin dose in reduced intensity conditioning reduces acute and chronic GVHD for patients with myeloid malignancies undergoing allo-SCT.
Devillier R; Crocchiolo R; Castagna L; Fürst S; El Cheikh J; Faucher C; Prebet T; Etienne A; Chabannon C; Vey N; Esterni B; Blaise D
Bone Marrow Transplant; 2012 May; 47(5):639-45. PubMed ID: 22307016
[TBL] [Abstract][Full Text] [Related]
14. Impacts of thymoglobulin in patients with acute leukemia in remission undergoing allogeneic HSCT from different donors.
Wakamatsu M; Terakura S; Ohashi K; Fukuda T; Ozawa Y; Kanamori H; Sawa M; Uchida N; Ota S; Matsushita A; Kanda Y; Nakamae H; Ichinohe T; Kato K; Murata M; Atsuta Y; Teshima T;
Blood Adv; 2019 Jan; 3(2):105-115. PubMed ID: 30626574
[TBL] [Abstract][Full Text] [Related]
15. The pan-Bcl2 Inhibitor AT101 Activates the Intrinsic Apoptotic Pathway and Causes DNA Damage in Acute Myeloid Leukemia Stem-Like Cells.
Zhang L; Zhou Y; Chen K; Shi P; Li Y; Deng M; Jiang Z; Wang X; Li P; Xu B
Target Oncol; 2017 Oct; 12(5):677-687. PubMed ID: 28710745
[TBL] [Abstract][Full Text] [Related]
16. Comparison of efficacy and safety between rabbit anti-thymocyte globulin and anti-T lymphocyte globulin in kidney transplantation from donation after cardiac death: a retrospective cohort study.
Chen GD; Lai XQ; Ko DS; Qiu J; Wang CX; Han M; Li J; Huang G; He XS; Chen LZ
Nephrology (Carlton); 2015 Aug; 20(8):539-43. PubMed ID: 25808082
[TBL] [Abstract][Full Text] [Related]
17. Association between anti-thymocyte globulin exposure and CD4+ immune reconstitution in paediatric haemopoietic cell transplantation: a multicentre, retrospective pharmacodynamic cohort analysis.
Admiraal R; van Kesteren C; Jol-van der Zijde CM; Lankester AC; Bierings MB; Egberts TC; van Tol MJ; Knibbe CA; Bredius RG; Boelens JJ
Lancet Haematol; 2015 May; 2(5):e194-203. PubMed ID: 26688094
[TBL] [Abstract][Full Text] [Related]
18. Optimal dose of rabbit thymoglobulin in conditioning regimens for unmanipulated, haploidentical, hematopoietic stem cell transplantation: Long-term outcomes of a prospective randomized trial.
Chang YJ; Wang Y; Mo XD; Zhang XH; Xu LP; Yan CH; Chen H; Chen YH; Chen Y; Han W; Wang FR; Wang JZ; Liu KY; Huang XJ
Cancer; 2017 Aug; 123(15):2881-2892. PubMed ID: 28301690
[TBL] [Abstract][Full Text] [Related]
19. A Chemotherapy-Only Regimen of Busulfan, Melphalan, and Fludarabine, and Rabbit Antithymocyte Globulin Followed by Allogeneic T-Cell Depleted Hematopoietic Stem Cell Transplantations for the Treatment of Myeloid Malignancies.
Spitzer B; Jakubowski AA; Papadopoulos EB; Fuller K; Hilden PD; Young JW; Barker JN; Koehne G; Perales MA; Hsu KC; van den Brink MR; Kernan NA; Prockop SE; Scaradavou A; Castro-Malaspina H; O'Reilly RJ; Boulad F
Biol Blood Marrow Transplant; 2017 Dec; 23(12):2088-2095. PubMed ID: 28711727
[TBL] [Abstract][Full Text] [Related]
20. Identification of TIM-3 as a Leukemic Stem Cell Surface Molecule in Primary Acute Myeloid Leukemia.
Kikushige Y; Miyamoto T
Oncology; 2015; 89 Suppl 1():28-32. PubMed ID: 26551150
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]